These deleterious effects observed with mutant viral stocks are likely to be a direct consequence of impaired AP-1 binding to the mutated 5103 fragment since wild-type and mutant HIV-1 particles from the viral stocks used in the infection studies are structurally similar at both the RNA and protein levels. The gene discussed is JUNB; the disease is infection.